These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17037313)

  • 1. [Renin-angiotensin system and insulin resistance: carbohydrate-metabolism disorders].
    Shimamoto K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1769-73. PubMed ID: 17037313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin sensitivity improving effect of ARB].
    Shimamoto K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():493-7. PubMed ID: 16897885
    [No Abstract]   [Full Text] [Related]  

  • 3. Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
    McGuire DK; Winterfield JR; Rytlewski JA; Ferrannini E
    Diab Vasc Dis Res; 2008 Mar; 5(1):59-66. PubMed ID: 18398815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.
    Poulter N; Hughes AD; Williams B; Brady AJ; McInnes G;
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):104-21. PubMed ID: 17083065
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiinflammatory action of angiotensin receptor blocker].
    Katagiri T; Takei M; Sakurai M; Matsuyama T; Sakai T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():506-11. PubMed ID: 16895219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
    Leung PS; de Gasparo M
    J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and hypertension: is the Renin system necessary?
    Gavras H; Brunner HR
    Hypertension; 2007 Jun; 49(6):e36; author reply e37. PubMed ID: 17389253
    [No Abstract]   [Full Text] [Related]  

  • 10. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.
    Putnam K; Shoemaker R; Yiannikouris F; Cassis LA
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1219-30. PubMed ID: 22227126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U; Deedwania PC
    Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.
    Kingston R
    J Hypertens; 2004 Oct; 22(10):1867-8. PubMed ID: 15361755
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes complications and the renin-angiotensin system.
    Perkins BA; Aiello LP; Krolewski AS
    N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288
    [No Abstract]   [Full Text] [Related]  

  • 14. "Effective" plasma renin activity: a derived measure for assessing residual plasma renin activity in patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Sealey JE; Parra D; Rosenstein R; Laragh JH
    Hypertension; 2010 Mar; 55(3):e16; author reply e17. PubMed ID: 20083722
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system and glucose homeostasis.
    Luther JM; Brown NJ
    Trends Pharmacol Sci; 2011 Dec; 32(12):734-9. PubMed ID: 21880378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 18. Interference with the renin-angiotensin system in heart failure.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):331-4. PubMed ID: 16468022
    [No Abstract]   [Full Text] [Related]  

  • 19. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.